These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33738751)

  • 1. Predictors of reproductive and non-reproductive outcomes of gonadotropin mediated pubertal induction in male patients with congenital hypogonadotropic hypogonadism (CHH).
    Cangiano B; Goggi G; Federici S; Bresesti C; Cotellessa L; Guizzardi F; Vezzoli V; Duminuco P; Persani L; Bonomi M
    J Endocrinol Invest; 2021 Nov; 44(11):2445-2454. PubMed ID: 33738751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations Among Genotype and Outcome in Chinese Male Patients With Congenital Hypogonadotropic Hypogonadism Under HCG Treatment.
    Chen Y; Sun T; Niu Y; Wang D; Xiong Z; Li C; Liu K; Qiu Y; Sun Y; Gong J; Wang T; Wang S; Xu H; Liu J
    J Sex Med; 2020 Apr; 17(4):645-657. PubMed ID: 32171629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients.
    Hao M; Nie M; Yu BQ; Gao YJ; Wang X; Ma WL; Huang QB; Zhang R; Mao JF; Wu XY
    Asian J Androl; 2020; 22(4):390-395. PubMed ID: 31464203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone.
    Grob F; Keshwani R; Angley E; Zacharin M
    J Paediatr Child Health; 2024; 60(2-3):53-57. PubMed ID: 38572627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
    Trabado S; Maione L; Bry-Gauillard H; Affres H; Salenave S; Sarfati J; Bouvattier C; Delemer B; Chanson P; Le Bouc Y; Brailly-Tabard S; Young J
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropins for testicular descent in cryptorchid congenital hypogonadotropic hypogonadism males beyond infancy.
    Sharma S; Shah R; Patil V; Lila AR; Sarathi V; Shah N; Bandgar T
    J Pediatr Endocrinol Metab; 2021 Jul; 34(7):917-924. PubMed ID: 33894111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GnRH stimulation testing and serum inhibin B in males: insufficient specificity for discriminating between congenital hypogonadotropic hypogonadism from constitutional delay of growth and puberty.
    Mosbah H; Bouvattier C; Maione L; Trabado S; De Filippo G; Cartes A; Donzeau A; Chanson P; Brailly-Tabard S; Dwyer AA; Coutant R; Young J
    Hum Reprod; 2020 Oct; 35(10):2312-2322. PubMed ID: 32862222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis.
    Alexander EC; Faruqi D; Farquhar R; Unadkat A; Ng Yin K; Hoskyns R; Varughese R; Howard SR
    Eur J Endocrinol; 2024 Jan; 190(1):S1-S11. PubMed ID: 38128110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
    Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal control of spermatogenesis in men: therapeutic aspects in hypogonadotropic hypogonadism.
    Pitteloud N; Dwyer A
    Ann Endocrinol (Paris); 2014 May; 75(2):98-100. PubMed ID: 24793994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital hypogonadotropic hypogonadism and Kallmann syndrome as models for studying hormonal regulation of human testicular endocrine functions.
    Trabado S; Lamothe S; Maione L; Bouvattier C; Sarfati J; Brailly-Tabard S; Young J
    Ann Endocrinol (Paris); 2014 May; 75(2):79-87. PubMed ID: 24815726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GNRHR-related central hypogonadism with spontaneous recovery - case report.
    Šmigoc Schweiger D; Davidović Povše M; Trebušak Podkrajšek K; Battelino T; Avbelj Stefanija M
    Ital J Pediatr; 2022 Nov; 48(1):184. PubMed ID: 36371229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism.
    Boeri L; Capogrosso P; Salonia A
    Curr Pharm Des; 2021; 27(24):2775-2783. PubMed ID: 32445446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism.
    Barrio R; de Luis D; Alonso M; Lamas A; Moreno JC
    Fertil Steril; 1999 Feb; 71(2):244-8. PubMed ID: 9988392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Puberty induction with recombinant gonadotropin: What impact on future fertility?
    Lambert AS; Bouvattier C
    Ann Endocrinol (Paris); 2022 Jun; 83(3):159-163. PubMed ID: 35436503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
    Huang Z; Wang X; Yu B; Ma W; Zhang P; Wu X; Nie M; Mao J
    Arch Endocrinol Metab; 2024 May; 68():e230101. PubMed ID: 38739523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome.
    Raivio T; Wikström AM; Dunkel L
    Eur J Endocrinol; 2007 Jan; 156(1):105-11. PubMed ID: 17218732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centres.
    Dwyer AA; McDonald IR; Cangiano B; Giovanelli L; Maione L; Silveira LFG; Raivio T; Latronico AC; Young J; Quinton R; Bonomi M; Persani L; Seminara SB; Lee CS
    Lancet Diabetes Endocrinol; 2024 Apr; 12(4):257-266. PubMed ID: 38437850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimüllerian hormone in patients with hypogonadotropic hypogonadism.
    Young J; Rey R; Couzinet B; Chanson P; Josso N; Schaison G
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2696-9. PubMed ID: 10443662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.